Immunotherapy: past, present and future

被引：441

作者：

Waldmann, TA ^{[1
]}

机构：

[1] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

NATURE MEDICINE | 2003年 / 9卷 / 03期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nm0303-269

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Harnessing the immune system to treat chronic infectious diseases or cancer is a major goal of immunotherapy. Among others, impediments to this aim include host failure to identify tumor antigens, tolerance to self and negative immunoregulatory mechanisms. But with recent progress, active and passive immunotherapy are proving themselves as effective therapeutic strategies.

引用

页码：269 / 277

页数：9

共 70 条

[41]

Parkhurst MR, 1996, J IMMUNOL, V157, P2539

[42] PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS [J].

PRESS, OW ;

EARY, JF ;

APPELBAUM, FR ;

MARTIN, PJ ;

NELP, WB ;

GLENN, S ;

FISHER, DR ;

PORTER, B ;

MATTHEWS, DC ;

GOOLEY, T ;

BERNSTEIN, ID .

LANCET, 1995, 346 (8971) :336-340

[43] A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts [J].

Press, OW ;

Corcoran, M ;

Subbiah, K ;

Hamlin, DK ;

Wilbur, DS ;

Johnson, T ;

Theodore, L ;

Yau, E ;

Mallett, R ;

Meyer, DL ;

Axworthy, D .

BLOOD, 2001, 98 (08) :2535-2543

[44] A HUMANIZED ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR [J].

QUEEN, C ;

SCHNEIDER, WP ;

SELICK, HE ;

PAYNE, PW ;

LANDOLFI, NF ;

DUNCAN, JF ;

AVDALOVIC, NM ;

LEVITT, M ;

JUNGHANS, RP ;

WALDMANN, TA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10029-10033

[45] The prime-boost strategy: exciting prospects for improved vaccination [J].

Ramshaw, IA ;

Ramsay, AJ .

IMMUNOLOGY TODAY, 2000, 21 (04) :163-165

[46]

ROBBINS PF, 1996, CURR OPIN IMMUNOL, V8, P626

[47] A new era for cancer immunotherapy based on the genes that encode cancer antigens [J].

Rosenberg, SA .

IMMUNITY, 1999, 10 (03) :281-287

[48] TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2 [J].

ROSENBERG, SA ;

YANG, JC ;

TOPALIAN, SL ;

SCHWARTZENTRUBER, DJ ;

WEBER, JS ;

PARKINSON, DR ;

SEIPP, CA ;

EINHORN, JH ;

WHITE, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12) :907-913

[49]

ROSENBERG SA, 1996, J IMMUNOTHER, V19, P8

[50] HUMAN NEOPLASMS ELICIT MULTIPLE SPECIFIC IMMUNE-RESPONSES IN THE AUTOLOGOUS HOST [J].

SAHIN, U ;

TURECI, O ;

SCHMITT, H ;

COCHLOVIUS, B ;

JOHANNES, T ;

SCHMITS, R ;

STENNER, F ;

LUO, GR ;

SCHOBERT, I ;

PFREUNDSCHUH, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11810-11813

← 1 2 3 4 5 6 7 →